Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,554,640
+$1,719,939 QoQ
Shares Held
119,838
+0.4% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,374,793,482 across 32 Diagnostics & Research names. LH ranks #18 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,116,336 | $2,565,126,216 | |
| 2 | NTRA |
Natera, Inc.
|
9,021,895 | $2,448,993,397 | |
| 3 | DHR |
Danaher Corp /De/
|
11,450,715 | $2,181,132,192 | |
| 4 | DGX |
Quest Diagnostics Inc
|
5,444,986 | $1,154,064,781 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
2,069,677 | $1,096,080,242 | |
| 6 | GH |
Guardant Health, Inc.
|
6,514,952 | $977,438,248 | |
| 7 | WAT |
Waters Corp /De/
|
2,177,958 | $816,821,367 | |
| 8 | RVTY |
Revvity, Inc.
|
5,530,850 | $615,362,370 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,554,640 | 119,838 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $31,834,701 | 119,316 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,137,461 | 120,127 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,501,166 | 120,188 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,634,554 | 120,508 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $47,462,668 | 203,930 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $27,022,380 | 117,837 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $26,407,513 | 118,165 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,819,827 | 117,045 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||